Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nekkar | 0TT | Nov 22, 2024 | 0.72 | -0.28 |
Nektar Therapeutics | ITH | Nov 22, 2024 | 0.95 | -0.21 |
NEL | D7G | Nov 22, 2024 | 0.25 | +0.43 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Nov 22, 2024 | 7.20 | +2.13 |
Nelly Group | CD20 | Nov 22, 2024 | 2.37 | +4.64 |
Nelnet, Inc. | NIJ | Nov 22, 2024 | 100.00 | +0.50 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Nov 22, 2024 | 18.80 | -0.53 |
Nemetschek SE | NEM | Nov 22, 2024 | 99.80 | +0.30 |
NENT Group B | NEB | Nov 22, 2024 | 0.06 | -0.71 |
Neo Performance Materials Inc | N14 | Nov 22, 2024 | 5.08 | 0.00 |
NEO-NEON | N2L | Nov 22, 2024 | 0.04 | +0.80 |
Neodecortech S.p.a. | FM2 | Nov 22, 2024 | 2.70 | 0.00 |
Neoen S.A. | N1N | Nov 22, 2024 | 39.26 | +0.05 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Nov 22, 2024 | 12.70 | +9.48 |
Neogen Corporation | NG2 | Nov 22, 2024 | 13.70 | -1.44 |
NeoGenomics, Inc. | NG9 | Nov 22, 2024 | 15.70 | +9.03 |
Neolife | 8JB | Nov 22, 2024 | 0.05 | -0.60 |
Neometals Ltd | 9R9 | Nov 22, 2024 | 0.05 | -1.19 |
NEOMETALS LTD SP.ADS/10 | 9R91 | Nov 22, 2024 | 0.43 | -2.27 |
NEON EQUITY NA O.N. | D77 | Nov 22, 2024 | 2.02 | 0.00 |
NeonMind Biosciences Inc | 6UF0 | Nov 22, 2024 | 0.01 | 0.00 |
Neosperience S.p.a | Y8E | Nov 22, 2024 | 0.54 | -2.16 |
NEOTECH METALS CORP. | V690 | Nov 22, 2024 | 0.07 | +1.52 |
Nephros | NPJP | Nov 22, 2024 | 1.41 | -4.73 |
Neptune Digital Assets Corp. | 1NW | Nov 22, 2024 | 0.48 | -15.79 |
Nerds On Site Inc | 3NS | Nov 22, 2024 | 0.02 | -16.00 |
Nerdwallet Inc | 6OI | Nov 22, 2024 | 13.20 | 0.00 |
NervGen Pharma Corp | 9UA | Nov 22, 2024 | 1.61 | +14.18 |
Neste | NEF | Nov 22, 2024 | 14.41 | +1.16 |
Neste OYJ American Depositary Receipts - Unsponsored | NEFA | Nov 22, 2024 | 6.95 | +2.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.